• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恢复正常之路:在部分接种疫苗的人群中,评估针对抗体耐药性严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体放松社交距离措施的程度。

Path to normality: Assessing the level of social-distancing measures relaxation against antibody-resistant SARS-CoV-2 variants in a partially-vaccinated population.

作者信息

Liang Jing-Bo, Yuan Hsiang-Yu, Li Kin-Kit, Wei Wan-In, Wong Samuel Yeung Shan, Tang Arthur, Riley Steven, Kwok Kin On

机构信息

Department of Biomedical Sciences, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong Special administrative regions, China.

Centre for Applied One Health Research and Policy Advice, City University of Hong Kong, Hong Kong Special administrative regions, China.

出版信息

Comput Struct Biotechnol J. 2022;20:4052-4059. doi: 10.1016/j.csbj.2022.07.048. Epub 2022 Jul 30.

DOI:10.1016/j.csbj.2022.07.048
PMID:35935805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9338450/
Abstract

INTRODUCTION

Two years into the coronavirus 2019 (COVID-19) pandemic, populations with less built-up immunity continued to devise ways to optimize social distancing measures (SDMs) relaxation levels for outbreaks triggered by SARS-CoV-2 and its variants to resume minimal economics activities while avoiding hospital system collapse.

METHOD

An age-stratified compartmental model featuring social mixing patterns was first fitted the incidence data in second wave in Hong Kong. Hypothetical scenario analysis was conducted by varying population mobility and vaccination coverages (VCs) to predict the number of hospital and intensive-care unit admissions in outbreaks initiated by ancestral strain and its variants (Alpha, Beta, Gamma, Delta and Omicron). Scenarios were "unsustainable" if either of admissions was larger than the maximum of its occupancy.

RESULTS

At VC of 65%, scenarios of full SDMs relaxation (mean daily social encounters prior to COVID-19 pandemic = 14.1 contacts) for outbreaks triggered by ancestral strain, Alpha and Beta were sustainable. Restricting levels of SDMs was required such that the optimal population mobility had to be reduced to 0.9, 0.65 and 0.37 for Gamma, Delta and Omicron associated outbreaks respectively. VC improvement from 65% to 75% and 95% allowed complete SDMs relaxation in Gamma-, and Delta-driven epidemic respectively. However, this was not supported for Omicron-triggered epidemic.

DISCUSSION

To seek a path to normality, speedy vaccine and booster distribution to the majority across all age groups is the first step. Gradual or complete SDMs lift could be considered if the hybrid immunity could be achieved due to high vaccination coverage and natural infection rate among vaccinated or the COVID-19 case fatality rate could be reduced similar to that for seasonal influenza to secure hospital system sustainability.

摘要

引言

在2019冠状病毒病(COVID-19)大流行的两年中,人群中已建立的免疫力较低,他们继续设法优化社交距离措施(SDM)的放松程度,以应对由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其变体引发的疫情,从而在避免医院系统崩溃的同时恢复最低限度的经济活动。

方法

首先将一个具有社会混合模式的年龄分层隔间模型拟合到香港第二波疫情的发病率数据中。通过改变人群流动性和疫苗接种覆盖率(VC)进行假设情景分析,以预测由原始毒株及其变体(阿尔法、贝塔、伽马、德尔塔和奥密克戎)引发的疫情中医院和重症监护病房的入院人数。如果任何一种入院人数超过其最大容量,则这些情景为“不可持续”。

结果

在疫苗接种覆盖率为65%时,由原始毒株、阿尔法和贝塔引发的疫情中,完全放松社交距离措施的情景(COVID-19大流行前平均每日社交接触次数=14.1次)是可持续的。对于与伽马、德尔塔和奥密克戎相关的疫情,需要限制社交距离措施的水平,使得最佳人群流动性分别降至0.9、0.65和0.37。疫苗接种覆盖率从65%提高到75%和95%分别允许在伽马和德尔塔驱动的疫情中完全放松社交距离措施。然而,对于奥密克戎引发的疫情则不支持这样做。

讨论

为了寻求恢复正常的途径,第一步是迅速为所有年龄组的大多数人分发疫苗和加强针。如果由于高疫苗接种覆盖率和接种者中的自然感染率而实现了混合免疫,或者COVID-19病死率可以降低到与季节性流感相似的水平以确保医院系统的可持续性,则可以考虑逐步或完全取消社交距离措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/2fda09aa2f74/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/e3976bbd866e/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/611bff3dc690/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/36d9899dbe63/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/c7143e380dfc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/2fda09aa2f74/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/e3976bbd866e/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/611bff3dc690/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/36d9899dbe63/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/c7143e380dfc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32e3/9363946/2fda09aa2f74/gr4.jpg

相似文献

1
Path to normality: Assessing the level of social-distancing measures relaxation against antibody-resistant SARS-CoV-2 variants in a partially-vaccinated population.恢复正常之路:在部分接种疫苗的人群中,评估针对抗体耐药性严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体放松社交距离措施的程度。
Comput Struct Biotechnol J. 2022;20:4052-4059. doi: 10.1016/j.csbj.2022.07.048. Epub 2022 Jul 30.
2
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新变种及针对冠状病毒(COVID-19)的新型疗法
3
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.非药物干预措施、疫苗接种和 SARS-CoV-2 德尔塔变异株在英国:一项数学建模研究。
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.
4
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株德尔塔迅速被奥密克戎取代:新冠病毒疾病病例数出现前所未有的激增,住院人数减少,上呼吸道病毒载量相当。
medRxiv. 2022 Jan 28:2022.01.26.22269927. doi: 10.1101/2022.01.26.22269927.
5
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.BNT162b2 和 CoronaVac 新冠疫苗对奥密克戎 BA.2 亚谱系引起的 SARS-CoV-2 无症状和有症状感染的有效性:一项前瞻性队列研究。
Lancet Infect Dis. 2023 Apr;23(4):421-434. doi: 10.1016/S1473-3099(22)00732-0. Epub 2022 Dec 12.
6
Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.接种科兴疫苗后对奥密克戎、伽马和德尔塔 SARS-CoV-2 变体产生中和抗体。
Rev Inst Med Trop Sao Paulo. 2022 Feb 25;64:e19. doi: 10.1590/S1678-9946202264019. eCollection 2022.
7
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
8
Population Behavior Changes Underlying Phasic Shifts of SARS-CoV-2 Exposure Settings Across 3 Omicron Epidemic Waves in Hong Kong: Prospective Cohort Study.人口行为变化是 SARS-CoV-2 暴露环境在香港 3 次奥密克戎疫情波次中阶段性转变的基础:前瞻性队列研究。
JMIR Public Health Surveill. 2024 Jun 19;10:e51498. doi: 10.2196/51498.
9
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.奥密克戎 BA.1 特异性 T 细胞应答在香港接种科兴或辉瑞疫苗的成年人中的观察性队列研究。
Lancet Microbe. 2023 Jun;4(6):e418-e430. doi: 10.1016/S2666-5247(23)00006-X. Epub 2023 Apr 20.
10
Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum.新型冠状病毒肺炎进展:康复期血清中和抗体的持久性、有效性及免疫逃逸
Pathogens. 2022 Dec 13;11(12):1531. doi: 10.3390/pathogens11121531.

引用本文的文献

1
Impact of vaccination on Omicron's escape variants: Insights from fine-scale modelling of waning immunity in Hong Kong.疫苗接种对奥密克戎逃逸变体的影响:来自香港免疫力下降精细尺度模型的见解
Infect Dis Model. 2024 Sep 16;10(1):129-138. doi: 10.1016/j.idm.2024.09.006. eCollection 2025 Mar.
2
Utilizing large language models in infectious disease transmission modelling for public health preparedness.在传染病传播建模中利用大语言模型进行公共卫生防范。
Comput Struct Biotechnol J. 2024 Aug 8;23:3254-3257. doi: 10.1016/j.csbj.2024.08.006. eCollection 2024 Dec.
3
Global age-structured spatial modeling for emerging infectious diseases like COVID-19.

本文引用的文献

1
Antibiotic use among COVID-19 patients in Hong Kong, January 2018 to March 2021.2018年1月至2021年3月香港新冠肺炎患者的抗生素使用情况
J Infect. 2022 Jun;84(6):e129-e132. doi: 10.1016/j.jinf.2022.02.014. Epub 2022 Feb 17.
2
The impact of contact tracing and testing on controlling COVID-19 outbreak without lockdown in Hong Kong: An observational study.接触者追踪与检测对香港在不实施封锁情况下控制新冠疫情的影响:一项观察性研究。
Lancet Reg Health West Pac. 2022 Mar;20:100374. doi: 10.1016/j.lanwpc.2021.100374. Epub 2022 Jan 15.
3
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.
针对COVID-19等新发传染病的全球年龄结构空间建模。
PNAS Nexus. 2023 Apr 25;2(5):pgad127. doi: 10.1093/pnasnexus/pgad127. eCollection 2023 May.
BNT162b2疫苗在南非针对奥密克戎变异株的有效性
N Engl J Med. 2022 Feb 3;386(5):494-496. doi: 10.1056/NEJMc2119270. Epub 2021 Dec 29.
4
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.5至11岁儿童中BNT162b2新冠疫苗的评估
N Engl J Med. 2022 Jan 6;386(1):35-46. doi: 10.1056/NEJMoa2116298. Epub 2021 Nov 9.
5
Likelihood of COVID-19 vaccination among primary school students in Hong Kong.香港小学生接种新冠疫苗的可能性。
Clin Microbiol Infect. 2022 Jan;28(1):142-144. doi: 10.1016/j.cmi.2021.09.029. Epub 2021 Oct 4.
6
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2(德尔塔)变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.
7
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.智利开展的灭活 SARS-CoV-2 疫苗有效性研究
N Engl J Med. 2021 Sep 2;385(10):875-884. doi: 10.1056/NEJMoa2107715. Epub 2021 Jul 7.
8
Psychobehavioral Responses and Likelihood of Receiving COVID-19 Vaccines during the Pandemic, Hong Kong.疫情期间香港的心理行为反应和接种 COVID-19 疫苗的可能性。
Emerg Infect Dis. 2021 Jul;27(7):1802-1810. doi: 10.3201/eid2707.210054.
9
Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.模拟 COVID-19 疫苗接种和非药物干预措施与感染、住院和死亡的关联。
JAMA Netw Open. 2021 Jun 1;4(6):e2110782. doi: 10.1001/jamanetworkopen.2021.10782.
10
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.BNT162b2新冠疫苗对B.1.1.7和B.1.351变异株的有效性
N Engl J Med. 2021 Jul 8;385(2):187-189. doi: 10.1056/NEJMc2104974. Epub 2021 May 5.